Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001641172-25-025645·Calidi Biotherapeutics, Inc.
Schedule 13G ownership disclosure
CALIDI BIOTHERAPEUTICS INC
Common Stock, $0.0001 par value · CUSIP: 320703408
Event date: 2025-08-20
- Filing-level shares
- 730,000.00
- Percent of class
- 14.46%
- Lincoln Alternative Strategies LLC
Shares: 730,000.00 · Class: 14.46%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001641172-25-025645
- Form type
- SCHEDULE 13G
- Filer
- Calidi Biotherapeutics, Inc.
- CIK
- CIK 1855485
- Filed
- Aug 27, 2025
- Reporting period
- Aug 20, 2025
- Description
- Schedule 13G beneficial ownership